Antineoplastic Combined Chemotherapy ProtocolsBurkitt LymphomaCancer Care Facilities
Neda Amirmokhtari
NPI1083288112
- Part D claims, 2024
- 480
- Publications
- 2
- Industry payments
- $265
- State license
- 1
- Year NPI issued
- 2021
- Practice address
- 543 Taylor Ave, Columbus, OH 43203
- Practice phone
- Call (913) 588-0348
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Neda Amirmokhtari's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Neda Amirmokhtari is a hematologist and oncologist in Columbus, Ohio
Neda Amirmokhtari practices in Columbus, Ohio.
Neda Amirmokhtari's NPI, 1083288112, was assigned on May 13, 2021. Neda Amirmokhtari holds Kansas license 9411682.
NPI and contact details
- NPI
- 1083288112NPI Registry (opens in a new tab)
- NPI enumeration date
- May 13, 2021
- NPI status
- Active
- Practice phone
- (913) 588-0348
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Neda Amirmokhtari's practice address is in Columbus, Ohio
Neda Amirmokhtari's practice address in the NPI Registry is 543 Taylor Ave, Columbus, OH 43203, in Franklin County. The practice phone is (913) 588-0348.
- NPI Registry address543 Taylor Ave, Columbus, OH 43203 · Franklin CountyPhone(913) 588-0348
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Neda Amirmokhtari's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Neda Amirmokhtari practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Neda Amirmokhtari's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Neda Amirmokhtari practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Neda Amirmokhtari is one of 460 hematologists and oncologists in Ohio
Hematology and oncology is Neda Amirmokhtari's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Neda Amirmokhtari is licensed in Kansas.
Specialties and state licenses
- Hematology and oncology, KansasPrimary
Hematologists and oncologists near Neda Amirmokhtari
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Neda Amirmokhtari's patients have a median age of 58
Across all payers, Dmand AI patient panel data puts Neda Amirmokhtari's median patient age at 58, with 67% women.
Neda Amirmokhtari's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 58
Patient panel by sex, all payers
- Women67%
- Men33%
Source: Dmand AI Patient Panel Data
Neda Amirmokhtari wrote 480 Medicare Part D claims in 2024
In 2024, Neda Amirmokhtari wrote 480 Medicare Part D claims for 91 patients. 76% of them were for generic drugs. CMS names the drug for 216 of them, across 10 drugs with 11 or more claims each, at $19,329 in total drug cost. In 2023, CMS named 512 claims across 24 drugs.
Part D claims, 2024480
Drugs named by CMS10
Total drug cost$19,329
Part D patients91
Neda Amirmokhtari's Part D claims by kind of drug, 2024
- Generic366 claims76%
- Brand-name and other114 claims24%
Neda Amirmokhtari's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Neda Amirmokhtari's Part D claims, 2024
- Antibiotics2%11 of 480 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5122024: 21658%
Drugs named by CMS: 10 in 2024, 24 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find hematologists and oncologists like Neda Amirmokhtari by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Neda Amirmokhtari has 2 publications on record
Dmand AI links 2 papers to Neda Amirmokhtari, published from 2023 to 2025. Neda Amirmokhtari's most frequent co-authors are David Alan Bond, MD, Anthony N. Audino, MD and Robert A. Baiocchi, MD.
Papers2
Years published2023 to 2025
Neda Amirmokhtari's most frequent co-authors
- David Alan Bond, MD2 shared papers
- Anthony N. Audino, MD1 shared paper
- Robert A. Baiocchi, MD1 shared paper
Recent publications by Neda Amirmokhtari
ComorbidityLymphoma, Mantle-Cell
See who Neda Amirmokhtari researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Neda Amirmokhtari works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Neda Amirmokhtari received $265 in industry payments in 2025
CMS Open Payments shows 3 general payments to Neda Amirmokhtari from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $146.
Companies that paid Neda Amirmokhtari the most, 2025 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Neda Amirmokhtari's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Neda Amirmokhtari
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Neda Amirmokhtari's NPI number?
Neda Amirmokhtari's NPI number is 1083288112. It was assigned on May 13, 2021, and it is active in the NPI Registry.
What does Neda Amirmokhtari specialize in?
Neda Amirmokhtari is a hematologist and oncologist in Columbus, Ohio. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Neda Amirmokhtari practice?
Neda Amirmokhtari practices at 543 Taylor Ave, Columbus, OH 43203.
What is Neda Amirmokhtari's office phone number?
The practice phone on file for Neda Amirmokhtari is (913) 588-0348.
What is Neda Amirmokhtari's medical license number?
Neda Amirmokhtari holds Kansas license 9411682.
What drugs does Neda Amirmokhtari prescribe most?
In 2024 Medicare Part D data, Neda Amirmokhtari's most prescribed drugs by claims were Atorvastatin Calcium, Albuterol Sulfate Hfa and Amlodipine Besylate.
Has Neda Amirmokhtari received payments from drug or device companies?
CMS Open Payments shows $265 in general payments to Neda Amirmokhtari from 3 companies from 2025 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Neda Amirmokhtari been practicing?
Neda Amirmokhtari's NPI was assigned in 2021.
Does Neda Amirmokhtari do research?
Dmand AI links 2 publications to Neda Amirmokhtari, published from 2023 to 2025.
Who does Neda Amirmokhtari publish with?
Neda Amirmokhtari's most frequent co-authors are David Alan Bond, MD (2 shared papers), Anthony N. Audino, MD (1 shared paper) and Robert A. Baiocchi, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Ohio by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card